Vanguard Group Inc Apollo Endosurgery, Inc. Transaction History

Vanguard Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$9.83 - $9.96 $3.22 Million - $3.26 Million	327,394 Added 22.31%	1,794,761 $17.8 Million
Q4 2022 Feb 10, 2023	BUY	$5.91 - $10.14 $624,030 - $1.07 Million	105,589 Added 7.75%	1,467,367 $14.6 Million
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.74 $56,210 - $103,796	15,400 Added 1.14%	1,361,778 $7.5 Million
Q1 2022 May 13, 2022	BUY	$5.01 - $8.77 $266,837 - $467,098	53,261 Added 4.12%	1,346,378 $8.15 Million
Q4 2021 Feb 14, 2022	BUY	$7.64 - $10.11 $3.97 Million - $5.26 Million	519,810 Added 67.22%	1,293,117 $10.9 Million
Q3 2021 Nov 12, 2021	BUY	$7.35 - $9.93 $776,123 - $1.05 Million	105,595 Added 15.81%	773,307 $7.01 Million
Q2 2021 Aug 13, 2021	BUY	$5.37 - $8.95 $3.59 Million - $5.98 Million	667,712 New	667,712 $5.41 Million

527K

Ticker APEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,686,500
Description
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible en...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.